drugset / Trial / NCT00003638

Vaccine Therapy in Treating Women With Metastatic Breast Cancer

NCT00003638

Phase 3 Completed 950 enrolled Oncothyreon Canada Inc.
RandomizedTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Vaccines may make the body build an immune response to kill tumor cells. It is not yet known whether THERATOPE vaccine therapy is more effective than standard vaccine therapy in treating metastatic breast cancer. PURPOSE: Randomized double blinded phase III trial to compare the effectiveness of THERATOPE vaccine therapy with that of standard vaccine therapy in treating women who have metastatic breast cancer.

Timeline

Start
1999-01
Primary completion
2007-01
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject THERATOPE STn-KLH Vaccine Subcutaneous
Subject keyhole limpet hemocyanin Vaccine Subcutaneous
Background Cyclophosphamide Other / unclassified Intravenous
Background Detox-B Unknown Subcutaneous

Indications